Bluejay Therapeutics
Travis Mowbray is a seasoned clinical trial management professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Senior Clinical Trial Manager at Bluejay Therapeutics since April 2024, Travis previously held similar roles at Tactogen and The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities included planning and executing early phase clinical trials while ensuring compliance with regulatory requirements. Prior positions include Clinical Research Manager at Janssen BioPharma, Associate Clinical Research Manager at Alios BioPharma, and Clinical Project Manager at Aerin Medical, among others. Travis holds a Bachelor’s degree in Philosophy from the University of Chicago and a Certificate in Clinical Trials Design & Management from the University of California, Santa Cruz.
This person is not in any teams
Bluejay Therapeutics
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative approaches with the potential for high rate offunctional cure: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. The company believes that by reducing hepatitis B surface antigen and restoring adaptive immunity a functional cure could be achieved for patients.